Rise in R&D activities for advancements in conjunctivitis treatment and the launch of innovative products drive the growth of the global conjunctivitis treatment market. Based on region, North America held the highest share of the global conjunctivitis treatment market in 2021, and is expected to continue its dominance by 2031. The COVID-19 pandemic negatively affected the conjunctivitis treatment market as there were restrictions on transportation of drugs due to lockdown restrictions.
Portland, OR, Oct. 03, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Conjunctivitis Treatment Market generated $4.2 billion in 2021, and is estimated to reach $6.1 billion by 2031, manifesting a CAGR of 3.8% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, value chain, top segments, and competitive landscape. This report offers extensive information to assist market players, investors, stakeholders, and startups in devising strategies to maintain sustainable growth and avail competitive advantage in the market.
Download Free Sample Report (220 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/18049
Report coverage & details:
Market Size in 2031
No. of Pages in Report
Drug Class, Disease Type, Distribution Channel, and Region.
Rise in R&D activities for advancements in conjunctivitis treatment
New product launches
Well-established healthcare infrastructure
The COVID-19 pandemic negatively affected the conjunctivitis treatment market as there were restrictions on transportation of drugs from one place to another due to lockdown restrictions.
Manufacturing companies of drugs and pharmaceuticals that are required for conjunctivitis treatment faced major challenges including shortage and supply restrictions of raw materials utilized for drug formulations.
Distribution channels suffered irregularities in demand for products from affected people. In addition, many treatment procedures were postponed to shift the focus on treating increase in the number of patients suffering from the Covid-19 and other life-threatening disorders. Treatments were carried out only in case of emergencies.
The launch of new drugs was postponed due to disruptions in research and development activities and formulations. This, in turn, impacted the revenue of major market players.
The research provides detailed segmentation of the global conjunctivitis treatment market based on drug class, disease type, and distribution channel, and region. The research analyzes segments and sub-segments for determining the largest revenue generating and highest-growing segments for market players and investors. Market size and forecasts for each segment and its sub-segments are offered in the report to outline the steps for achieving the growth.
Based on drug class, the anti-allergic segment held the highest share in 2021, contributing to more than two-fifths of the total share, and is expected to continue its leadership status throughout the forecast period. In addition, this segment is projected to manifest the highest CAGR of 4.0% from 2022 to 2031. The research also analyzes the segments including antibiotics, antiviral, and artificial tears.
Based on disease type, the allergic conjunctivitis segment contributed to the highest share in 2021, accounting for nearly half of the global conjunctivitis treatment market, and is estimated to continue its lead in terms of revenue during the forecast period. Moreover, this segment is expected to manifest the highest CAGR of 4.3% from 2022 to 2031. The report provides an extensive analysis of segments including bacterial conjunctivitis and viral conjunctivitis.
Based on distribution channel, the hospital pharmacy segment contributed to the largest share in 2021, accounting for nearly half of the global market, and is expected to maintain its dominance by 2031. However, the online pharmacy segment is projected to grow at the highest CAGR of 4.3% during the forecast period. The report also analyzes the retail pharmacy segment.
Based on region, North America held the highest share in 2021, contributing to nearly two-fifths of the global conjunctivitis treatment market, and is expected to continue its dominance by 2031. However, Asia-Pacific is projected to grow at the fastest CAGR of 4.4% during the forecast period. The research also analyzes regions including Europe and LAMEA.
The research provides detailed analysis of leading players of the global conjunctivitis treatment market. Key players analyzed in the research include AbbVie Inc., AFT pharmaceuticals, Ajanta Pharma Limited, Bausch Health Companies Inc., Alembic Pharmaceuticals Ltd, Grevis Pharmaceutical Private Limited, Cipla, Inc., Jabs Biotech Pvt. Ltd., Indoco Remedies Ltd., Johnson & Johnson Services Inc., Sun Pharmaceuticals Industries Ltd., JAWA Pharmaceuticals Pvt. Ltd, Ocular Therapeutics, Inc., Novartis AG, Spectra Vision Care Pvt. Ltd, Santen Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Esoteric Testing Market by Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing, and Other Testing), Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass-Spectrometry, Real Time Polymerase Chain Reaction, DNA Sequencing, Flow Cytometry, and Other Technologies), and End User (Hospital-based Laboratories and Independent and Reference Laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2030
Dermatology Devices Market by Product Type (Diagnostic Devices and Treatment Devices), Application (Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, and Warts), End User (Hospitals, Clinics, and Others): Opportunity Analysis and Industry Forecast, 2021-2030
Cryotherapy Market by Product (Cryosurgery Devices, Localized Cryotherapy Devices, and Cryochambers & Cryosuanas), Application (Surgical Applications, Pain Management, Sports Medicine & Physiotherapy, and Beauty Applications), End User (Hospitals & Clinics, Cryotherapy Centers and Spas & Fitness Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030
Compounding Pharmacies Market by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements, Others), by Route of Administration (Oral, Topical, Others), by Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs): Global Opportunity Analysis and Industry Forecast, 2021-2031
Cancer Diagnostics Market by Product (Consumables and Instruments), Application (Breast Cancer, Breast Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Skin Cancer, Ovarian Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Cervical Cancer, and Others), and End Use (Hospitals & Clinics, Diagnostic Laboratories, Diagnostic Centers, and Research Institutes): Opportunity Analysis and Industry Forecast, 2021-2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Follow Us on Blog: https://www.globalhealthcareindustry.com/
CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 firstname.lastname@example.org Web: https://www.alliedmarketresearch.com/reports-store/life-sciences